Protein Summary
Plays an important role in the degradation of some oligopeptides. The protein encoded by this gene is a post-proline cleaving aminopeptidase expressed in quiescent lymphocytes. The resting lymphocytes are maintained through suppression of apoptosis, a state which is disrupted by inhibition of this novel serine protease. The enzyme has strong sequence homology with prolylcarboxypeptidase and is active at both acidic and neutral pH. [provided by RefSeq, Jul 2008]
- ENST00000371579
- ENSP00000360635
- ENSG00000176978
- DPP2
- QPP
- QPP
- DPP2
- DPPII
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
transcription factor perturbation | 0.91 | ||
cell type or tissue | 0.8 | ||
histone modification site profile | 0.79 | ||
disease perturbation | 0.74 | ||
cellular component | 0.69 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 306.23 (req: < 5)
Gene RIFs: 5 (req: <= 3)
Antibodies: 259 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 306.23 (req: >= 5)
Gene RIFs: 5 (req: > 3)
Antibodies: 259 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 4
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 236
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0